Efficacy of the myrtle syrup in the treatment of novel corona

Phase 3

Completed

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20180923041093N3
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

18-65 years old
Developed mild to moderate COVID-19 based on Fifth Edition of the Novel Corona Virus Guidelines
Candidate for outpatient treatment

Exclusion Criteria

Allergy to myrtle
Asthma or allergy
Hypertension
Diabetes
Pregnancy/lactation
Congestive heart failure
Chronic renal failure
Chemotherapy
Taking Corticosteroid
Immune deficiency

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Temperature. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Termometer.;Cough (severity-frequency). Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Fisman Cough Severity Score.;Weakness. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Muscular pain. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Asking patients using visual analog scale (VAS).;Respiratory rate. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Counting the number of breaths per minute.

Secondary Outcome Measures

Name	Time	Method
Hospital admssion. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of admission to total patients in each group.;Mortality. Timepoint: 0-1-2-3-4-7-14 days after starting intervention. Method of measurement: Ratio of the number of deaths to total patients in each group.